GlaxoSmithKline Pakistan Limited has declared an interim cash dividend for its shareholders. The Board of Directors approved a dividend of PKR 7.00 per share, representing 70% of the face value, for the half-year ending June 30, 2026.
- Interim cash dividend of PKR 7.00 per share (70% of face value)
- Financial period: Half year ending June 30, 2026
- Book closure dates: September 3, 2026 to September 4, 2026 (inclusive)
- Last date for transfer of shares: September 2, 2026
- Payment will be made electronically to shareholders' designated bank accounts
- Withholding tax rates: 15% for filers, 30% for non-filers
- Shareholders must provide bank account details for dividend payment